Vaneck Vectors Pharmaceutical etf shares owned by Aptus Capital Advisors
Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Aptus Capital Advisors
from 13F filings
Historical chart of Aptus Capital Advisors investment in Vaneck Vectors Pharmaceutical etf
Tip: Access up to 7 years of quarterly data
All positions including Vaneck Vectors Pharmaceutical etf held by Aptus Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Aptus Capital Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $48k | 528 | 90.36 |
| 2025-06-30 | $46k | 524 | 88.02 |
| 2025-03-31 | $48k | 521 | 91.19 |
| 2024-12-31 | $46k | 531 | 86.33 |
| 2024-09-30 | $98k | 1.0k | 95.03 |
| 2024-06-30 | $94k | 1.0k | 91.48 |
| 2024-03-31 | $94k | 1.0k | 90.70 |
Top funds holding Vaneck Vectors Pharmaceutical etf
View all funds holding Vaneck Vectors Pharmaceutical etf